Ameritas Advisory Services’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$263K Buy
+4,105
New +$270K 0.01% 996
2025
Q4
Sell
-3,644
Closed -$274K 1393
2025
Q3
$274K Sell
3,644
-1,100
-23% -$82K 0.02% 538
2025
Q2
$351K Buy
4,744
+319
+7% +$22.2K 0.02% 589
2025
Q1
$348K Buy
4,425
+107
+2% +$9.2K 0.01% 662
2024
Q4
$338K Sell
4,318
-115
-3% -$9.78K 0.01% 692
2024
Q3
$416K Buy
4,433
+340
+8% +$28.5K 0.02% 591
2024
Q2
$319K Buy
4,093
+698
+21% +$56.9K 0.01% 710
2024
Q1
$273K Sell
3,395
-781
-19% -$65K 0.01% 735
2023
Q4
$343K Buy
4,176
+249
+6% +$17.4K 0.02% 516
2023
Q3
$258K Buy
3,927
+730
+23% +$53.1K 0.01% 676
2023
Q2
$255K Sell
3,197
-778
-20% -$62.1K 0.03% 454
2023
Q1
$330K Buy
+3,975
New +$284K 0.02% 614

Other funds holding GEHC

Ameritas Advisory Services's GEHC Position: Q2 2026 in Review

Ameritas Advisory Services opened a new position in GE HealthCare (GEHC) in Q2 2026: 4,105 shares worth $263K. The stake represents 0.01% of the portfolio and ranks #996 among its holdings. This is a return to the name: Ameritas Advisory Services previously reported a position in GEHC as recently as Q3 2025.

Ameritas Advisory Services first reported a position in GEHC in Q1 2023 and has held it in 12 quarters since. The position peaked at $416K in Q3 2024. 1,229 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Ameritas Advisory Services held 4,105 shares of GE HealthCare worth $263K as of Q2 2026.
  • GE HealthCare was a new Ameritas Advisory Services position in Q2 2026.
  • GE HealthCare made up 0.01% of Ameritas Advisory Services's portfolio in Q2 2026, its #996 holding.
  • Ameritas Advisory Services first reported a position in GE HealthCare in Q1 2023 and has held it in 12 quarters since.
  • Ameritas Advisory Services's GE HealthCare position peaked at $416K in Q3 2024.
  • 1,229 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.